Vimarsana
Biggest News Aggregation in the World

Page 25 - Breakthrough Device News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Breakthrough Device. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Breakthrough Device Today - Breaking & Trending Today

Pulse Medical receives FDA Breakthrough Device Designation for its μFR® system - Vimarsana News

Pulse Medical receives FDA Breakthrough Device Designation for its μFR® system

/PRNewswire/ -- Pulse Medical Technology, Inc. (Pulse Medical) 4th generation μFR® system has received an FDA Breakthrough Device designation. Pulse Medical,...

FDA Accepts Priority Review of Pegulicianine Imaging Agent for Residual Breast Cancer - Vimarsana News

FDA Accepts Priority Review of Pegulicianine Imaging Agent for Residual Breast Cancer

The imaging agent and visualization system will be an adjunct to standard of care to reduce residual cancer in the lumpectomy cavity during initial surgery.

Orlucent Receives FDA Breakthrough Device Designation for Handheld Mole Imaging System - Vimarsana News

Orlucent Receives FDA Breakthrough Device Designation for Handheld Mole Imaging System

/PRNewswire/ -- Orlucent, Inc., a company focused on clinical assessment of suspicious moles, today announced the U.S. Food and Drug Administration (FDA) has...

CORVIA MEDICAL RELEASES TWO-YEAR CLINICAL TRIAL RESULTS CONFIRMING SUSTAINED BENEFIT AND SAFETY OF ITS ATRIAL SHUNT IN HEART FAILURE PATIENTS - Vimarsana News

CORVIA MEDICAL RELEASES TWO-YEAR CLINICAL TRIAL RESULTS CONFIRMING SUSTAINED BENEFIT AND SAFETY OF ITS ATRIAL SHUNT IN HEART FAILURE PATIENTS

/PRNewswire/ -- Corvia Medical, Inc, a company dedicated to transforming the treatment of heart failure, today announced two-year results from its REDUCE...

Locate Bio receives FDA breakthrough designation for spinal fusion treatment - Vimarsana News

Locate Bio receives FDA breakthrough designation for spinal fusion treatment

Locate Bio, a UK-based orthobiologics company, has announced that the US Food and Drug Administration (FDA) has granted Breakthrough Device designation for LDGraft.